Funding to fuel next key milestones as company continues to target asthma, COPD and infectious respiratory diseases in 2022 Philadelphia, PA January 5, 2022 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and...
Strados Labs harnesses the power of smart sensors and machine learning to aid in early detection and predictions of worsening respiratory diseases for enhanced patient care Philadelphia, PA, December 16, 2021 – Strados Labs, a medical technology company harnessing...
CE Mark expands the company’s reach to support customers on a global scale Philadelphia, PA, November 18, 2021 – Strados Labs, a medical technology company harnessing the power of smart sensors to aid in early detection and predictions of worsening diseases for...
Philadelphia, PA December 22, 2020 — Strados Labs, a health technology developer of remote respiratory devices and software, today announced it has received FDA Class II 510(k) clearance for its first product, RESP™, a system for measuring, recording and analyzing...
Small Business Innovation Research Program Provides Seed Funding for R&D Philadelphia, PA, August 13, 2020 – Strados Labs has been awarded a National Science Foundation (NSF) Phase I Small Business Innovation Research (SBIR) grant for $224,470 to conduct research...
As hospitals and ICUs begin to fill following the coronavirus outbreak, this remote monitoring platform could save lives, time, and money Philadelphia, PA, March 19, 2020 – An innovative remote respiratory device created by Strados Labs has the potential to save...
